Latest Daily News

More Stories

May 18, 2018

George Daneker Jr., MD, is chief medical officer of Cancer Treatment Centers of America (CTCA) and began attending the ASCO Annual Meeting in the 1990s.

Read more
May 17, 2018

Long-time ASCO Annual Meeting attendee Leslie Samuel, MD, provides advice to new attendees on how to get the most out of the Meeting.

Read more
May 17, 2018

The Education Session “Next-Generation Diagnostics Beyond Tissue” on June 4* promises to provide an in-depth look at the novel innovations in noninvasive cancer molecular diagnostic platforms as well as their potential and challenges.

Read more

May 17, 2018

Systems that allow remote monitoring of symptoms in patients undergoing chemotherapy have been shown to help improve patients’ quality of life and increase their overall survival (OS).

Read more

May 17, 2018

Pilot Study of an Internet-based Self-Management Program for Symptom Control in Patients With Early Stage Breast Cancer.

Read more

May 16, 2018

ASCO recently released a new Clinical Practice Guideline on the management of malignant pleural mesothelioma.

Read more

May 16, 2018

After two recent clinical trials provided long-awaited new information on the role of lymph node management in patients with melanoma, a panel was formed to update the 2012 ASCO-Society of Surgical Oncology (SSO) guidelines for sentinel lymph node (SLN) biopsy.

Read more

May 14, 2018

Data presented during the 2012 ASCO Annual Meeting demonstrated the potential of anti–PD-1 and anti–PD-L1 therapy for multiple cancers and introduced groundbreaking change in oncology research and treatment.

Read more

May 13, 2018

National Comprehensive Cancer Network guidelines were recently updated to allow for a shorter duration of adjuvant chemotherapy for patients with low-risk stage III colon cancer.

Read more

May 13, 2018

The treatment paradigm of breast cancer has celebrated the successes of targeted therapy for decades. Currently, the hormone receptor and HER2 statuses of a breast tumor continue to drive the selection of therapy for patients with early-stage breast cancer and metastatic breast cancer (mBC).

Read more

May 14, 2018

Rare genitourinary neoplasms encompass diseases of the kidney, bladder, prostate, and penile tract that are of uncommon histology. These entities often pose a major diagnostic and treatment dilemma to the treating physician.

Read more

May 14, 2018

The routine collection of patient-reported outcomes (PROs) is becoming more common in oncology practice.

Read more

May 14, 2018

Evidence from multiple positive trials, support from literature reviews and editorials, and the endorsements of professional societies and funding agencies all promote the use of patient-reported outcomes (PROs) in clinical cancer care.

Read more

May 14, 2018

Immune checkpoints are inhibitory receptors expressed by immune cells that suppress T-cell and other immune cell activation in order to maintain peripheral tolerance and prevent autoimmunity.

Read more

May 14, 2018

The therapeutic landscape of advanced non–small cell lung cancer (NSCLC) has seen a rapid shift in the last 2 years with the introduction of immunotherapy into treatment algorithms.

Read more

May 14, 2018

Cancer is predominantly a disease of older adults, with the majority of new cancer diagnoses occurring in adults over age 65 and the cancer incidence rate peaking around the eighth decade of life.

Read more

May 14, 2018

Approximately 50% of high-grade serous ovarian cancers harbor genetic or epigenetic alterations in gene members of the homologous recombination repair (HRR) pathway.

Read more

May 14, 2018

Although the diagnosis and treatment for malignancy can be an overwhelming experience for all patients and their caregivers, patients with disabilities in particular present unique challenges.

Read more

May 14, 2018

Cannabis use in Western medicine was initially popularized by Irish physician William B. O’Shaughnessy in 1840. It was included in the U.S. Pharmacopeia shortly afterward and was often prescribed for rheumatism, cholera, tetanus, rabies, and labor pain.

Read more

May 11, 2018

Enrique Soto, MD, of the Salvador Zubiran National Institute of Medical Science and Nutrition, in Mexico City, grew up to the sound of seismic alarms. Mexico City is located on a fault line, and Dr. Soto was no stranger to feeling the earth shake beneath his feet.

Read more